Xealth
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Revenues | 3.3m | 4.7m | 6.5m | 7.8m | 14.5m |
% growth | - | 42 % | 38 % | 19 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$8.5m | Seed | ||
$11.0m | Series A | ||
$3.0m | Series A | ||
$6.0m | Early VC | ||
$24.0m | Series B | ||
Total Funding | €47.7m |
Related Content
Recent News about Xealth
EditXealth operates as an integrated digital prescribing and analytics platform, primarily serving healthcare providers such as physicians and care teams. The company operates in the digital health market, offering a solution that allows medical professionals to prescribe digital health content, applications, and services with the same ease as traditional medications. This platform enhances patient education and engagement by extending the patient-physician interaction beyond the examination room. Xealth's business model revolves around providing a subscription-based service to healthcare institutions, which in turn use the platform to improve patient outcomes and streamline care processes. Revenue is generated through these subscriptions and potentially through partnerships with digital health content providers. The platform's analytics capabilities also offer valuable insights into patient engagement and treatment efficacy, further adding value to healthcare providers.
Keywords: digital prescribing, healthcare platform, patient engagement, physician tools, digital health content, analytics, patient education, care teams, subscription model, healthcare innovation.